Share This Profile
Share this profile on Facebook.
Link to this profile on LinkedIn.
Tweet this profile on Twitter.
Email a link to this profile.
See other services through which you can share this profile.
This profile was last updated on 11/19/15  and contains information from public web pages and contributions from the ZoomInfo community.

Dr. Samir Mitragotri

Wrong Dr. Samir Mitragotri?

Professor of Systems Biology and ...

Phone: (805) ***-****  
Email: s***@***.edu
Local Address:  California , United States
University of California , Santa Barbara
5221 Cheadle Hall
Santa Barbara , California 93106
United States

Company Description: The University of California, Santa Barbara (UCSB) is one of 10 universities in the University of California system, and is one of only 62 research-intensive...   more

Employment History

Board Memberships and Affiliations


  • Ph.D. , Chemical Engineering
    Massachusetts Institute of Technology
  • Ph.D. , Chemical Engineering
184 Total References
Web References
"With diabetes, there's a tremendous need ..., 19 Nov 2015 [cached]
"With diabetes, there's a tremendous need for oral delivery," said Samir Mitragotri, a professor in the Department of Chemical Engineering at the University of California - Santa Barbara.
"People take insulin several times a day and delivery by needles is a big challenge," said Mitragotri, who specialises in targeted drug delivery.
"When you deliver insulin by injection, it goes first through the peripheral bloodstream and then to blood circulation in the liver," Mitragotri said.
Oral delivery would take a more direct route, he added, and, from a physiological point of view, a better one.
"This is the first essential step in showing that these patches can deliver insulin," Mitragotri said.
Like any other novel therapy, however, it must undergo additional stages of testing and improvement before it can be considered as a viable treatment for diabetes.
The drug-loaded mucoadhesive patches show early promise for other forms of therapy, as well, researchers said.
"We can deliver many proteins that are currently injected," Mitragotri added.
This technology has great utility in ..., 22 Oct 2015 [cached]
This technology has great utility in localized as well as systemic delivery of drugs," says Samir Mitragotri, a professor of systems biology and bioengineering at the University of California at Santa Barbara. Mitragotri was also an author of the 1995 Science paper on ultrasound drug delivery but was not involved in the new research.
"Through this unique collaboration, we ..., 19 Mar 2015 [cached]
"Through this unique collaboration, we have essentially established the foundation of a novel therapy," said Samir Mitragotri, professor of chemical engineering at UCSB.
"The unique thing about these particles is that when you shine a laser on them, they efficiently convert light into heat via a process called surface plasmon resonance," said Mitragotri.
"If you deactivate these overproducing glands, you're basically treating the root cause of the acne," said Mitragotri.
According to the research, which is published in the Journal of Controlled Release, this protocol would have several benefits over conventional treatments. Called selective photothermolysis, the method does not irritate or dry the skin's surface. In addition, it poses no risk of resistance or long-term side effects that can occur with antibiotics or other systemic treatments.
"It's highly local but highly potent as well," Mitragotri said of the treatment. "I think this would be beneficial in addressing the concerns regarding other, conventional treatments. According to Mitragotri, this photothermolysis method is particularly suited to patients with advanced, severe or difficult-to-treat acne.
The combination of feedback-controlled ..., 22 June 2015 [cached]
The combination of feedback-controlled insulin delivery and painless skin patches is "exciting and innovative," said Samir Mitragotri, director of the Center for Bioengineering at the University of California Santa Barbara.
Samir Mitragotri, ..., 16 Nov 2015 [cached]
Samir Mitragotri, PhD
Samir Mitragotri, PhD
Samir Mitragotri, PhD
Dr. Mitragotri, whose research interests lie in novel methods of drug delivery, has published more than 80 peer-reviewed journal articles, edits several journals in the field of drug delivery, and is a co-inventor in more than 30 issued and pending patents. He has received numerous awards for his work, including the Technology Review Young Innovator award, and distinctions from the Controlled Release Society, the American Pharmaceutical Association, and the American Institute of Chemical Engineers.
Other People with the name "Mitragotri":
Other ZoomInfo Searches
Accelerate your business with the industry's most comprehensive profiles on business people and companies.
Find business contacts by city, industry and title. Our B2B directory has just-verified and in-depth profiles, plus the market's top tools for searching, targeting and tracking.
Atlanta | Boston | Chicago | Houston | Los Angeles | New York
Browse ZoomInfo's business people directory. Our professional profiles include verified contact information, biography, work history, affiliations and more.
Browse ZoomInfo's company directory. Our company profiles include corporate background information, detailed descriptions, and links to comprehensive employee profiles with verified contact information.